Public Sector Pension Investment Board Increases Stock Position in Core Laboratories Inc. $CLB

Key Points

• The Public Sector Pension Investment Board increased its stake in Core Laboratories Inc. by 26.9% during the first quarter, now owning a total of 148,476 shares valued at approximately $2.2 million.
• Core Laboratories reported an earnings per share (EPS) of $0.19 for the last quarter, slightly exceeding analyst expectations, while the revenue decreased by 0.3% year-over-year.
• The company declared a quarterly dividend of $0.01 per share, resulting in an annualized yield of 0.4%, with the payout ratio set at 6.45%.

Public Sector Pension Investment Board raised its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 26.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 148,476 shares of the oil and gas company's stock after acquiring an additional 31,485 shares during the quarter. Public Sector Pension Investment Board owned approximately 0.32% of Core Laboratories worth $2,226,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also modified their holdings of the company. Millennium Management LLC boosted its stake in shares of Core Laboratories by 429.0% during the 4th quarter. Millennium Management LLC now owns 65,616 shares of the oil and gas company's stock worth $1,136,000 after acquiring an additional 53,213 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of Core Laboratories by 19.8% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 69,184 shares of the oil and gas company's stock worth $1,037,000 after acquiring an additional 11,438 shares during the last quarter. Assetmark Inc. lifted its stake in shares of Core Laboratories by 92.5% during the 1st quarter. Assetmark Inc. now owns 2,887 shares of the oil and gas company's stock valued at $43,000 after buying an additional 1,387 shares in the last quarter. Northern Trust Corp lifted its stake in shares of Core Laboratories by 15.6% during the 4th quarter. Northern Trust Corp now owns 577,752 shares of the oil and gas company's stock valued at $10,001,000 after buying an additional 78,173 shares in the last quarter. Finally, Envestnet Asset Management Inc. lifted its stake in shares of Core Laboratories by 1.3% during the 1st quarter. Envestnet Asset Management Inc. now owns 254,005 shares of the oil and gas company's stock valued at $3,808,000 after buying an additional 3,357 shares in the last quarter. Hedge funds and other institutional investors own 97.81% of the company's stock.

Core Laboratories Price Performance

Shares of Core Laboratories stock traded up $0.03 during trading hours on Tuesday, reaching $11.12. The company's stock had a trading volume of 605,003 shares, compared to its average volume of 461,341. The firm has a 50 day moving average price of $11.52 and a 200-day moving average price of $12.68. Core Laboratories Inc. has a one year low of $9.72 and a one year high of $21.83. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.27 and a quick ratio of 1.70. The stock has a market cap of $521.18 million, a P/E ratio of 17.93, a P/E/G ratio of 3.35 and a beta of 1.41.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.01. The firm had revenue of $130.16 million for the quarter, compared to the consensus estimate of $129.19 million. Core Laboratories had a net margin of 5.73% and a return on equity of 14.15%. The business's quarterly revenue was down .3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.22 EPS. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS. On average, analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, August 25th. Shareholders of record on Monday, August 4th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Monday, August 4th. Core Laboratories's dividend payout ratio is currently 6.45%.

Analyst Ratings Changes

A number of research firms recently weighed in on CLB. Citigroup lowered their target price on shares of Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 13th. Stifel Nicolaus lowered their target price on shares of Core Laboratories from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Zacks Research upgraded shares of Core Laboratories from a "strong sell" rating to a "hold" rating in a research note on Friday, August 15th. Finally, Wall Street Zen upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a research note on Saturday, July 26th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Core Laboratories presently has an average rating of "Hold" and an average target price of $12.50.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.